Alembic Pharma Shares Jump on USFDA Approval for Lamotrigine Tablets
This approval enhances Alembic Pharma’s portfolio, which now totals 216 ANDAs from the USFDA, including 188 final and 28 tentative approvals.
Alembic Pharma shares jump 5% on final USFDA nod to Seizure treatment drug
This approval adds to Alembic Pharma's growing portfolio, which now includes 216 ANDA approvals from the USFDA, comprising 188 final approvals and 28 tentative approvals.
Alembic Pharma Gets US FDA Nod For Generic Medication To Treat Seizure
Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June 2024, according to IQVIA.
Alembic Pharma stock gains over 6% after USFDA approval for drug
The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.
Alembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER
Vadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application
Alembic Pharma share price gains 5% after USFDA okays seizures drug
Alembic Pharma share price surged after the United States Food and Drug Administration (USFDA) gave final approval for Lamotrigine ExtendedRelease Tablets USP, 200 mg, 250 mg, and 300 mg.
Alembic Pharma jumps 4% on US FDA approves anti-seizure drug worth $163 million
The estimated market value for Lamotrigine Extended-Release Tablets is approximately $163 million for the year ending June 2024, according to IQVIA.
Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution
Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Alcaftadine Ophthalmic Solution.
Drug Store News2d
Alembic receives FDA nod for 2 generics
The FDA has approved Alembic's generic Albenza and generic Invega. Alembic has received The Food and Drug Administration’s ...
Fortune India45m
₹5000 pm PM internship scheme rolls out; M&M, Max Life, Alembic evince interest
This is the first step in the direction of the budget announcement this year to provide internships to one crore youth in the ...
Mahindra, Max Life Insurance, Alembic Pharma take lead in PM internship scheme
Mahindra Group, Max Life Insurance, and Alembic Pharmaceuticals are leading internships under a new central scheme, with ...
Selected interns will be paid Rs 4,500 per month as stipend by the government through Direct Benefit Transfer (DBT).
Selected interns will be paid Rs 4,500 per month as stipend by the government through Direct Benefit Transfer (DBT).